TrueBlue - TBI Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TBI shares.
View TBI analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12 month price objectives for TrueBlue's shares. Their TBI share price forecasts range from $20.00 to $21.00. On average, they anticipate the company's share price to reach $20.50 in the next year. This suggests a possible upside of 18.5% from the stock's current price.
View analysts price targets for TBI or view top-rated stocks among Wall Street analysts.

TrueBlue's stock was trading at $19.58 at the beginning of 2023. Since then, TBI shares have decreased by 11.6% and is now trading at $17.30.
View the best growth stocks for 2023 here.

TrueBlue saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 677,800 shares, an increase of 22.5% from the January 31st total of 553,300 shares. Based on an average daily trading volume, of 169,000 shares, the days-to-cover ratio is presently 4.0 days. Currently, 2.1% of the company's stock are short sold.
View TrueBlue's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 24th 2023.
View our TBI earnings forecast.

TrueBlue, Inc. (NYSE:TBI) issued its earnings results on Wednesday, February, 1st. The business services provider reported $0.43 EPS for the quarter, beating the consensus estimate of $0.41 by $0.02. The business services provider had revenue of $557.70 million for the quarter, compared to the consensus estimate of $562.93 million. TrueBlue had a net margin of 2.76% and a trailing twelve-month return on equity of 16.95%. TrueBlue's revenue was down 10.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.69 EPS.

ETFs with the largest weight of TrueBlue (NYSE:TBI) stock in their portfolio include First Trust Dow Jones Select Microcap Index Fund (FDM), Invesco S&P SmallCap 600 Pure Value ETF (RZV), Pacer US Small Cap Cash Cows 100 ETF (CALF), Invesco S&P SmallCap Industrials ETF (PSCI), Strategas Global Policy Opportunities ETF (SAGP).Invesco S&P SmallCap 600 Revenue ETF (RWJ) and

TrueBlue updated its first quarter 2023 earnings guidance on Wednesday, February, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.00 million-$480.00 million, compared to the consensus revenue estimate of $492.18 million.

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by many different retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (7.75%), Pzena Investment Management LLC (6.74%), JPMorgan Chase & Co. (2.22%), Charles Schwab Investment Management Inc. (2.18%), Geode Capital Management LLC (1.82%) and Morgan Stanley (1.59%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Garrett Ferencz, Richard Christensen, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends.

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TBI stock can currently be purchased for approximately $17.30.

TrueBlue (NYSE:TBI) has a market capitalization of $567.84 million and generates $2.25 billion in revenue each year. The business services provider earns $62.27 million in net income (profit) each year or $1.86 on an earnings per share basis.

The company employs 6,500 workers across the globe.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.